Corrigendum: Building a genomic framework for prospective MRSA surveillance in the United Kingdom and the Republic of Ireland (Genome Research (2016) 26 (263-270) DOI: 10.1101/gr.196709.115);Building a genomic framework for prospective MRSA surveillance in the United Kingdom and the Republic of Ireland

Genome Research

Volumn 26, Issue 2, 2016, Pages 263-270

  Reuter, Sandra ^a,b   Estee Torok, M ^a,c,d   Holden, Matthew T G ^b,e   Reynolds, Rosy ^f,g   Raven, Kathy E ^a   Blane, Beth ^a   Donker, Tjibbe ^h   Bentley, Stephen D ^b   Aanensen, David M ⁱ   Grundmann, Hajo ^h,j   Feil, Edward J ^k   Spratt, Brian G ⁱ   Parkhill, Julian ^b   Peacock, Sharon J ^a,b,c,d,l  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF ST ANDREWS   (United Kingdom)

^f 11 the Wharf   (United Kingdom)

^g NORTH BRISTOL NHS TRUST   (United Kingdom)

^h UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

ⁱ IMPERIAL COLLEGE LONDON   (United Kingdom)

^j UNIVERSITY OF FREIBURG   (Germany)

^k Claverton Down   (United Kingdom)

^l LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENOME; BACTERIUM ISOLATE; CLONE; CONTROLLED STUDY; DISEASE SURVEILLANCE; GENE SEQUENCE; IRELAND; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PHYLOGENETIC TREE; PRIORITY JOURNAL; UNITED KINGDOM; DNA SEQUENCE; EPIDEMIC; EPIDEMIOLOGICAL MONITORING; GENETICS; HUMAN; MICROBIOLOGY; MOLECULAR DIAGNOSIS; PENICILLIN RESISTANCE; PHYLOGENY; STAPHYLOCOCCAL INFECTIONS;

DISEASE OUTBREAKS; EPIDEMIOLOGICAL MONITORING; GENOME, BACTERIAL; HUMANS; IRELAND; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR DIAGNOSTIC TECHNIQUES; PHYLOGENY; SEQUENCE ANALYSIS, DNA; STAPHYLOCOCCAL INFECTIONS; UNITED KINGDOM;

EID: 84956885526     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.228155.117     Document Type: Erratum

References (36)

1. Afshinnekoo E, Meydan C, Chowdhury S, Jaroudi D, Boyer C, Bernstein N, Maritz JM, Reeves D, Gandara J, Chhangawala S, et al. 2015. Geospatial resolution of human and bacterial diversity with city-scale metagenom-ics. Cell Syst 1: 72-87.
2. Alam MT, Read TD, Petit RA, Boyle-Vavra S, Miller LG, Eells SJ, Daum RS, David MZ. 2015. Transmission and microevolution of USA300 MRSA in U.S. households: evidence from whole-genome sequencing. MBio 6: e00054-15.
3. Bartels MD, Larner-Svensson H, Meiniche H, Kristoffersen K, Schonning K, Nielsen JB, Rohde SM, Christensen LB, Skibsted AW, Jarlov JO, et al. 2015. Monitoring meticillin resistant Staphylococcus aureus and its spreadin Copenhagen, Denmark, 2013, through routine whole genome sequencing. Eurosurveillance 20: 20-28.
4. Boetzer M, Pirovano W. 2012. Toward almost closed genomes with GapFiller. Genome Biol 13: R56.
5. Boetzer M, Henkel CV, Jansen HJ, Butler D, Pirovano W. 2011. Scaffolding pre-assembled contigs using SSPACE. Bioinformatics 27: 578-579.
6. Castanheira M, Watters AA, Mendes RE, Farrell DJ, Jones RN. 2010. Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008). J Antimicrob Chemother 65: 1353-1358.
7. Cooper JE, Feil EJ. 2004. Multilocus sequence typing: What is resolved? Trends Microbiol 12: 373-377.
8. Cox RA, Conquest C, Mallaghan C, Marples RR. 1995. A major outbreak of methicillin-resistant Staphylococcus aureus caused by a new phage-type (EMRSA-16). J Hosp Infect 29: 87-106.
9. Donker T, Wallinga J, Grundmann H. 2014. Dispersal of antibiotic-resistant high-risk clones by hospital networks: Changing the patient direction can make all the difference. J Hosp Infect 86: 34-41.
10. Ellington MJ, Hope R, Livermore DM, Kearns AM, Henderson K, Cookson BD, Pearson A, Johnson AP. 2010. Decline of EMRSA-16 amongst meth-icillin-resistant Staphylococcus aureus causing bacteraemias in the UK between 2001 and 2007. J Antimicrob Chemother 65: 446-448.
11. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. 2000. Multilocus sequence typing for characterization ofmethicillin-resistant and methicil-lin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 38: 1008-1015.
12. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. 2002. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci 99: 7687-7692.
13. Harris SR, Feil EJ, Holden MT, Quail MA, Nickerson EK, Chantratita N, Gardete S, Tavares A, Day N, Lindsay JA, et al. 2010. Evolution of MRSA during hospital transmission and intercontinental spread. Science 327: 469-474.
14. Harris SR, Cartwright EJ, Török ME, Holden MT, Brown NM, Ogilvy-Stuart AL, Ellington MJ, Quail MA, Bentley SD, Parkhill J, et al. 2013. Whole-genome sequencing for analysis of an outbreak of methicillin-resistant Staphylococcus aureus: a descriptive study. Lancet Infect Dis 13: 130-136.
15. Holden MT, Feil EJ, Lindsay JA, Peacock SJ, Day NP, Enright MC, Foster TJ, Moore CE, Hurst L, Atkin R, et al. 2004. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci 101: 9786-9791.
16. Holden MT, Hsu LY, Kurt K, Weinert LA, Mather AE, Harris SR, Strommenger B, Layer F, Witte W, de Lencastre H, et al. 2013. A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic. Genome Res 23: 653-664.
17. Jevons MP. 1961. Celbenin-resistant Staphylococci. Br Med J 1: 124-125.
18. Johnson AP, Pearson A, Duckworth G. 2005. Surveillance and epidemiology of MRSA bacteraemia in the UK. J Antimicrob Chemother 56: 455-462.
19. Johnson AP, Davies J, Guy R, Abernethy J, Sheridan E, Pearson A, Duckworth G. 2012. Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years. J Antimicrob Chemother 67: 802-809.
20. Kerr S, Kerr GE, Mackintosh CA, Marples RR. 1990. A survey of methicillin-resistant Staphylococcus aureus affecting patients in England and Wales. J Hosp Infect 16: 35-48.
21. Knight GM, Budd EL, Whitney L, Thornley A, Al-Ghusein H, Planche T, Lindsay JA. 2012. Shift in dominant hospital-associated methicillin-re-sistant Staphylococcus aureus (HA-MRSA) clones over time. J Antimicrob Chemother 67: 2514-2522.
22. Köser CU, Holden MT, Ellington MJ, Cartwright EJ, Brown NM, Ogilvy-Stuart AL, Hsu LY, Chewapreecha C, Croucher NJ, Harris SR, et al. 2012. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N Engl J Med 366: 2267-2275.
23. Kuroda M, Ohta T, Uchiyama I, Baba T, Yuzawa H, Kobayashi I, Cui L, Oguchi A, Aoki K, Nagai Y, et al. 2001. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 357: 1225-1240.
24. Letunic I, Bork P. 2011. Interactive Tree Of Life v2: online annotation and display of phylogenetic trees made easy. Nucleic Acids Res 39(Web Server issue): W475-W478.
25. Marples RR, Reith S. 1992. Methicillin-resistant Staphylococcus aureus in England and Wales. Commun Dis Rep CDR Rev 2: R25-R29.
26. McAdam PR, Templeton KE, Edwards GF, Holden MT, Feil EJ, Aanensen DM, Bargawi HJ, Spratt BG, Bentley SD, Parkhill J, et al. 2012. Molecular tracing of the emergence, adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci 109: 9107-9112.
27. Miller RR, Price JR, Batty EM, Didelot X, Wyllie D, Golubchik T, Crook DW, Paul J, Peto TEA, Wilson DJ, et al. 2014. Healthcare-associated outbreak of meticillin-resistant Staphylococcus aureus bacteraemia: role of a cryptic variant of an epidemic clone. J Hosp Infect 86: 83-89.
28. Nubel U, Nachtnebel M, Falkenhorst G, Benzler J, Hecht J, Kube M, Brocker F, Moelling K, Buhrer C, Gastmeier P, et al. 2013. MRSA transmission on a neonatal intensive care unit: epidemiological and genome-based phy-logenetic analyses. PLoS One 8.
29. Peng Y, Ou Q, Lin D, Xu P, Li Y, Ye X, Zhou J, Yao Z. 2015. Metro system in Guangzhou as a hazardous reservoir of methicillin-resistant Staphylococci: findings from a point-prevalence molecular epidemiolog-ic study. Sci Rep 5: 16087.
30. Reynolds R, Hope R, Williams L; BSAC Working Parties on Resistance Surveillance. 2008. Survey, laboratory and statistical methods for the BSAC Resistance Surveillance Programmes. J Antimicrob Chemother 62 (Suppl 2): ii15-ii28.
31. Richardson JF, Reith S. 1993. Characterization of a strain of methicillin-re-sistant Staphylococcus aureus (EMRSA-15) by conventional and molecular methods. J Hosp Infect 25: 45-52.
32. Shanson DC. 1981. Antibiotic-resistant Staphylococcus aureus. J Hosp Infect 2: 11-36.
33. Stamatakis A, Ludwig T, Meier H. 2005. RAxML-III: a fast program for maximum likelihood-based inference of large phylogenetic trees. Bioinformatics 21: 456-463.
34. Török ME, Harris SR, Cartwright EJ, Raven KE, Brown NM, Allison ME, Greaves D, Quail MA, Limmathurotsakul D, Holden MT, et al. 2014. Zero tolerance for healthcare-associated MRSA bacteraemia: Is it realistic? J Antimicrob Chemother 69: 2238-2245.
35. Uhlemann AC, Dordel J, Knox JR, Raven KE, Parkhill J, Holden MT, Peacock SJ, Lowy FD. 2014. Molecular tracing of the emergence, diversification, and transmission of S. aureus sequence type 8 in a New York community. Proc Natl Acad Sci 111: 6738-6743.
36. Zerbino DR, Birney E. 2008. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res 18: 821-829.